Learn More
Although lung cancer incidence rates and mortalities are still low in the Arab world as compared to Europe or USA, they is gradually increasing in the region. Furthermore, there is great variation between different parts of the Arab world. For instance, the age-standardized rates (ASRs) for lung cancer incidence are about 15 fold higher in Tunisia than in(More)
BACKGROUND Breast cancer is the most frequent cause of cancer death in women worldwide, but global disparities in breast cancer control persist, due to a lack of a comprehensive breast cancer control strategy in many countries. OBJECTIVES To identify and compare the need for breast cancer control strategies in Asia, Latin America and the Middle East/North(More)
BACKGROUND Patients with advanced non-small cell lung cancer (NSCLC) have no curative treatment options; therefore, improving their quality of life (QOL) is an important goal. Gefitinib, an epidermal growth factor receptor (EGFR) inhibitor, is a safe oral agent that may be of benefit to a specific population of NSCLC. PATIENTS AND METHODS A Phase II(More)
Translational research has succeeded in expanding our medical knowledge and bringing many discoveries to the clinic. However, the prevailing research enterprise is plagued with many challenges that may limit the ability to realize the full potential benefits of these advances. The main challenge of current research approaches is the inability to reach all(More)
  • 1